ARSA (Search Result) Help

Search Result

Facet

Division

now loading

    Organism_facet

    now loading

      List of Entries

      1 - entries / Number of founds: 5044771  
        PrimaryAccessionNumber Definition SequenceLength MolecularType Organism
      DM115368 WO 2008156172-A/40: Double-stranded nucleic acid molecules suitable for prevention or treatment of uterine cancer, breast cancer, or bladder cancer, Agent for inhibiting cancer cell proliferation, and Medicine. 21 RNA synthetic construct
      DM115372 WO 2008156172-A/44: Double-stranded nucleic acid molecules suitable for prevention or treatment of uterine cancer, breast cancer, or bladder cancer, Agent for inhibiting cancer cell proliferation, and Medicine. 21 DNA synthetic construct
      DM115374 WO 2008156172-A/46: Double-stranded nucleic acid molecules suitable for prevention or treatment of uterine cancer, breast cancer, or bladder cancer, Agent for inhibiting cancer cell proliferation, and Medicine. 21 DNA synthetic construct
      BD162200 JP 2002173500-A/7: Cancer inhibitor, method for enhancing the expression of cancer inhibitor, and method for inhibiting mammalian cancer. 24 DNA synthetic construct
      BD162197 JP 2002173500-A/4: Cancer inhibitor, method for enhancing the expression of cancer inhibitor, and method for inhibiting mammalian cancer. 30 DNA synthetic construct
      HZ455483 JP 2015213503-A/1: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR. 21 RNA synthetic construct
      HZ455486 JP 2015213503-A/4: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR. 21 RNA synthetic construct
      HZ455489 JP 2015213503-A/7: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR. 20 DNA synthetic construct
      HZ455492 JP 2015213503-A/10: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR. 21 DNA synthetic construct
      HZ455495 JP 2015213503-A/13: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR. 21 DNA synthetic construct
      HZ455498 JP 2015213503-A/16: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR. 55 RNA synthetic construct
      BD162198 JP 2002173500-A/5: Cancer inhibitor, method for enhancing the expression of cancer inhibitor, and method for inhibiting mammalian cancer. 30 DNA synthetic construct
      BD570838 JP 2002173500-A/8: Cancer inhibitor, method for enhancing the expression of cancer inhibitor, and method for inhibiting mammalian cancer. 179 PRT Canis sp.
      BD827399 JP 2005506514-A/9: METHODS OF DIAGNOSING COLORECTAL CANCER AND/OR BREAST CANCER, COMPOSITIONS, AND METHODS OF SCREENING FOR COLORECTAL CANCER AND/OR BREAST CANCER MODULATORS. 187 PRT Mus musculus
      BD827402 JP 2005506514-A/12: METHODS OF DIAGNOSING COLORECTAL CANCER AND/OR BREAST CANCER, COMPOSITIONS, AND METHODS OF SCREENING FOR COLORECTAL CANCER AND/OR BREAST CANCER MODULATORS. 5 PRT unidentified
      HZ455484 JP 2015213503-A/2: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR. 21 RNA synthetic construct
      HZ455487 JP 2015213503-A/5: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR. 22 DNA synthetic construct
      HZ455490 JP 2015213503-A/8: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR. 20 DNA synthetic construct
      HZ455493 JP 2015213503-A/11: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR. 22 DNA synthetic construct
      HZ455496 JP 2015213503-A/14: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR. 21 DNA synthetic construct
      HZ455499 JP 2015213503-A/17: METHOD AND KIT FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR SCREENING FOR CANCER THERAPEUTIC DRUG, CANCER CELL PROLIFERATION INHIBITOR, CANCER THERAPEUTIC DRUG, AND METHOD AND KIT FOR PREDICTING DRUG EFFICACY OF mTOR INHIBITOR. 55 RNA synthetic construct
      DD183396 JP 2005192484-A/27: A method for judging prognosis of cancer, a vector for gene therapy of cancer and a pharmaceutical composition for cancer using miRNA. 20 DNA synthetic construct
      DD183401 JP 2005192484-A/32: A method for judging prognosis of cancer, a vector for gene therapy of cancer and a pharmaceutical composition for cancer using miRNA. 20 DNA synthetic construct
      DD183406 JP 2005192484-A/37: A method for judging prognosis of cancer, a vector for gene therapy of cancer and a pharmaceutical composition for cancer using miRNA. 20 DNA synthetic construct
      DD183411 JP 2005192484-A/42: A method for judging prognosis of cancer, a vector for gene therapy of cancer and a pharmaceutical composition for cancer using miRNA. 32 DNA synthetic construct
      DM163100 WO 2009037857-A/1: Agent for diagnosing or treating lung cancer, prostafe cancer, breast cancer and melanoma. 3769 DNA unidentified
      BD162196 JP 2002173500-A/3: Cancer inhibitor, method for enhancing the expression of cancer inhibitor, and method for inhibiting mammalian cancer. 30 DNA synthetic construct
      DD183398 JP 2005192484-A/29: A method for judging prognosis of cancer, a vector for gene therapy of cancer and a pharmaceutical composition for cancer using miRNA. 20 DNA synthetic construct
      DD183403 JP 2005192484-A/34: A method for judging prognosis of cancer, a vector for gene therapy of cancer and a pharmaceutical composition for cancer using miRNA. 20 DNA synthetic construct
      DD183408 JP 2005192484-A/39: A method for judging prognosis of cancer, a vector for gene therapy of cancer and a pharmaceutical composition for cancer using miRNA. 20 DNA synthetic construct
      Now loading
      PAGE TOP